Phase 4 Comparative Study of Peginterferon alfa-2a vs Peginterferon alfa-2b for Treatment of Chronic Hepatitis C Genotype 4

Trial Profile

Phase 4 Comparative Study of Peginterferon alfa-2a vs Peginterferon alfa-2b for Treatment of Chronic Hepatitis C Genotype 4

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2012

At a glance

  • Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jul 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 28 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 02 Mar 2009 Planned end date changed from 1 Oct 2008 to 1 May 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top